374 related articles for article (PubMed ID: 27116680)
1. Quality of Care for Cervical and Endometrial Cancer Patients: The Impact of Different Techniques of Sentinel Lymph Node Mapping on Patient Satisfaction.
Buda A; Elisei F; Palazzi S; De Ponti E; Arosio M; Vecchione F; Dell'Anna T; Cuzzocrea M; Bussi B; Giuliani D; Di Martino G; Crivellaro C
Ann Surg Oncol; 2016 Sep; 23(9):2975-81. PubMed ID: 27116680
[TBL] [Abstract][Full Text] [Related]
2. Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer (99m)Tc and/or Blue Dye.
Buda A; Crivellaro C; Elisei F; Di Martino G; Guerra L; De Ponti E; Cuzzocrea M; Giuliani D; Sina F; Magni S; Landoni C; Milani R
Ann Surg Oncol; 2016 Jul; 23(7):2183-91. PubMed ID: 26714944
[TBL] [Abstract][Full Text] [Related]
3. Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye.
Buda A; Papadia A; Di Martino G; Imboden S; Bussi B; Guerra L; De Ponti E; Reato C; Gasparri ML; Crivellaro C; Mueller M
J Minim Invasive Gynecol; 2018; 25(3):455-460. PubMed ID: 29032256
[TBL] [Abstract][Full Text] [Related]
4. From Conventional Radiotracer Tc-99(m) with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach.
Buda A; Papadia A; Zapardiel I; Vizza E; Ghezzi F; De Ponti E; Lissoni AA; Imboden S; Diestro MD; Verri D; Gasparri ML; Bussi B; Di Martino G; de la Noval BD; Mueller M; Crivellaro C
Ann Surg Oncol; 2016 Sep; 23(9):2959-65. PubMed ID: 27126631
[TBL] [Abstract][Full Text] [Related]
5. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
[TBL] [Abstract][Full Text] [Related]
7. Optimizing Strategies for Sentinel Lymph Node Mapping in Early-Stage Cervical and Endometrial Cancer: Comparison of Real-Time Fluorescence With Indocyanine Green and Methylene Blue.
Buda A; Di Martino G; Vecchione F; Bussi B; Dell'Anna T; Palazzi S; Cantù MG; Marchette MD; Milani R
Int J Gynecol Cancer; 2015 Oct; 25(8):1513-8. PubMed ID: 26397069
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99
Papadia A; Zapardiel I; Bussi B; Ghezzi F; Ceccaroni M; De Ponti E; Elisei F; Imboden S; de la Noval BD; Gasparri ML; Di Martino G; De Santiago J; Mueller M; Vecchione F; Dell'Orto F; Buda A
J Cancer Res Clin Oncol; 2017 Mar; 143(3):475-480. PubMed ID: 27812854
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node detection using 99mTc combined with methylene blue cervical injection for endometrial cancer surgical management: a prospective study.
López-De la Manzanara Cano C; Cordero García JM; Martín-Francisco C; Pascual-Ramírez J; Parra CP; Céspedes Casas C
Int J Gynecol Cancer; 2014 Jul; 24(6):1048-53. PubMed ID: 24927249
[TBL] [Abstract][Full Text] [Related]
11. Combining Indocyanine Green and Tc
Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
[TBL] [Abstract][Full Text] [Related]
12. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
El-Agwany AS; Meleis MH
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
[TBL] [Abstract][Full Text] [Related]
13. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.
Nagar H; Wietek N; Goodall RJ; Hughes W; Schmidt-Hansen M; Morrison J
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013021. PubMed ID: 34106467
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue.
Papadia A; Gasparri ML; Buda A; Mueller MD
J Cancer Res Clin Oncol; 2017 Oct; 143(10):2039-2048. PubMed ID: 28828528
[TBL] [Abstract][Full Text] [Related]
15. Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer.
How J; Gotlieb WH; Press JZ; Abitbol J; Pelmus M; Ferenczy A; Probst S; Gotlieb R; Brin S; Lau S
Gynecol Oncol; 2015 Jun; 137(3):436-42. PubMed ID: 25870917
[TBL] [Abstract][Full Text] [Related]
16. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
Siesto G; Romano F; Fiamengo B; Vitobello D
J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
[TBL] [Abstract][Full Text] [Related]
17. Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer.
Rozenholc A; Samouelian V; Warkus T; Gauthier P; Provencher D; Sauthier P; Gauthier F; Drakopoulos P; Cormier B
Gynecol Oncol; 2019 Jun; 153(3):500-504. PubMed ID: 30902369
[TBL] [Abstract][Full Text] [Related]
18. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
[TBL] [Abstract][Full Text] [Related]
20. The Added Value of SPECT/CT in Sentinel Lymph Nodes Mapping for Endometrial Carcinoma.
Naaman Y; Pinkas L; Roitman S; Ikher S; Oustinov N; Vaisbuch E; Yachnin A; Ben-Arie A
Ann Surg Oncol; 2016 Feb; 23(2):450-5. PubMed ID: 26438438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
